Japanese and Dutch researchers have used sustained interferon alpha to successfully repress the symptoms and growth of severe acute respiratory syndrome in SARS-infected monkeys.

“It is significant that a drug expected to be effective against SARS has been found among those that can be administered to humans,” said Masato Tashiro, a senior researcher at the National Institute of Infectious Diseases in Japan who has taken part in the research.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.